Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Haleon PLC ( (GB:HLN) ) just unveiled an update.
Haleon plc has launched a share buyback programme of up to £500 million, in line with its capital allocation priorities and focus on delivering attractive returns to shareholders. The company has appointed HSBC Bank plc to execute the purchases independently on several UK and European trading venues, with all acquired shares to be cancelled to reduce Haleon’s share capital.
The programme begins immediately and is scheduled to run no later than 19 August 2026, operating under existing and future shareholder authorities and within UK market abuse and listing rules. While there is no guarantee the full amount will be deployed, the move underlines management’s confidence in the business and its commitment to capital discipline, and Haleon will provide ongoing regulatory updates as buybacks are executed.
The most recent analyst rating on (GB:HLN) stock is a Buy with a £450.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Spark’s Take on GB:HLN Stock
According to Spark, TipRanks’ AI Analyst, GB:HLN is a Neutral.
The score is driven primarily by solid financial performance (consistent free cash flow and improving profitability) and a cautiously positive earnings outlook supported by margin gains and cost savings. This is tempered by weaker near-term technical momentum and only moderate valuation support.
To see Spark’s full report on GB:HLN stock, click here.
More about Haleon PLC
Haleon plc is a consumer health company focused on improving everyday health through a broad portfolio of over-the-counter products. Its brands span six major categories, including oral health, vitamins, minerals and supplements, pain relief, respiratory health, digestive health, and therapeutic skin health, with well-known names such as Sensodyne, Panadol, Advil, Centrum, Voltaren and Theraflu.
Average Trading Volume: 18,258,665
Technical Sentiment Signal: Buy
Current Market Cap: £32.63B
For detailed information about HLN stock, go to TipRanks’ Stock Analysis page.